Answer to Question 1
Ahmed demonstrated a type I, IgE-mediated hypersensitivity reaction as indicated by his rhinoconjunctivitis and asthmatic symptoms. The rapid onset of his respiratory symptoms shortly after putting on the gloves is also typical of the type I response. Latex allergy can also be attributed to a type IV, T-cell-mediated response that presents with dermatological signs and symptoms that are more delayed in their onset.
In a type I hypersensitivity disorder, T2H cells differentiate in response to an allergen and in turn release IL-3, IL-4, and IL-5. Interleukins-3 and 5 recruit and activate eosinophils, while interleukin-4 stimulates the differentiation of B cells into IgE-producing plasma cells. The IgE antibodies in turn sensitize mast cells, which subsequently undergo degranulation when exposed to the allergen. Mast cells produce vasodilation and smooth muscle spasm. Both mast cells and eosinophils contribute to the mucosal edema, secretion, and bronchospasm seen in type I hypersensitivity responses.
The latex proteins responsible for allergic reactions bind readily with the cornstarch used to coat gloves. In any environment where gloves are frequently changed, the cornstarch becomes airborne and liberates aerosolized latex. A susceptible individual can react to the airborne proteins without having had contact with the latex material itself.
The proteins responsible for latex allergy reactions have a similar structure to the proteins found in bananas, avocado, kiwis, tomatoes, and chestnuts. Those with latex allergy often show cross-sensitivity to these foods.
Answer to Question 2
A number of factors increase the risk of HIV transmission from mother to infant. A mother who exhibits a low CD4+ count or high viral load during pregnancy increases the risk of transmitting the disease to the unborn child. Delayed delivery after rupture of the amniotic sac is another factor that puts the fetus at risk. Transmission can occur in utero, during delivery, or with breast-feeding.
HAART therapy refers to highly active antiretroviral therapy. The treatment protocol involves the administration of two or three antiretroviral medications that collectively destroy the HIV at various stages of replication. The aim of the therapy is to reduce the presence of HIV RNA to an undetectable level while increasing CD4+ cell counts. Zidovudine is a particularly effective antiretroviral medication to be administered to the pregnant woman as it greatly reduces the risk of perinatal transmission to the fetus. Some antiretrovirals, however, are teratogenic and should not be administered to the mother during the first trimester.
An opportunistic infection occurs when otherwise benign or common microorganisms cause disease in a compromised host. Individuals with HIV are prone to opportunistic infection because of CD4+ deficiency. The level of CD4+ cells directly correlates with the risk of developing an opportunistic infection. Viral load is another risk factor, and higher HIV RNA levels predispose the individual to opportunistic illness.